Shots:

• The US FDA has granted clearance for Abbott’s EnSite X EP System with EnSite OT to treat abnormal heart rhythms. The device is designed to create 3-dimensional maps of the heart & is available in the US & EU
• The system includes EnSite OT, utilizes the Advisor HD Grid catheter to provide true EGMs & provides a 360-degree view of the heart regardless of catheter orientation for cardiac mapping. The device boost the utility of Advisor HD Grid catheter to generate real-time, stable, three-dimensional models of the heart
• In addition, EnSite X EP System with EnSite OT is the 1st mapping system & offers cardiac visualization methods to help maximize data collection

Ref: Abbott | Image: Forbes